Skip to main content
Erschienen in: Surgical Endoscopy 9/2013

01.09.2013

Initial experience from a large referral center with robotic-assisted Ivor Lewis esophagogastrectomy for oncologic purposes

verfasst von: Sebastian G. de la Fuente, Jill Weber, Sarah E. Hoffe, Ravi Shridhar, Richard Karl, Kenneth L. Meredith

Erschienen in: Surgical Endoscopy | Ausgabe 9/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

We report our initial experience of patients undergoing robotic-assisted Ivor Lewis esophagogastrectomy (RAIL) for oncologic purposes at a large-referral center.

Methods

A retrospective review of all consecutive patients undergoing RAIL from 2010–2011 was performed. Basic demographics were recorded. Oncologic variables recorded included: tumor type, location, postoperative tumor margins, and nodal harvest. Immediate 30-day postoperative complications also were analyzed.

Results

Fifty patients underwent RAIL with median age of 66 (range 42–82) years. The mean body mass index was 28.6 ± 0.7 kg/m2; 54 % and the majority had an American Society of Anesthesiologists classification of 3. The mean and median number of lymph nodes retrieved during surgery was 20 ± 1.4 and 18.5 respectively. R0 resections were achieved in all patients. Postoperative complications occurred in 14 (28 %) patients, including atrial fibrillation in 5 (10 %), pneumonia in 5 (10 %), anastomotic leak in 1 (2 %), conduit staple line leak in 1 (2 %), and chyle leak in 2 (4 %). The median ICU stay and length of hospitalization (LOH) were 2 and 9 days respectively. Total mean operating time calculated from time of skin incision to wound closure was 445 ± 85 minutes; however, operative times decreased over time. Similarly, there was a trend toward lower complications after the first 29 cases but this did not reach statistical significance. There were no in-hospital mortalities.

Conclusions

We demonstrated that RAIL for esophageal cancer can be performed safely and may be associated with fewer complications after a learning curve, shorter ICU stay, and LOH.
Literatur
1.
Zurück zum Zitat Safranek PM, Cubitt J, Booth MI et al (2010) Review of open and minimal access approaches to oesophagectomy for cancer. Br J Surg 97:1845–1853PubMedCrossRef Safranek PM, Cubitt J, Booth MI et al (2010) Review of open and minimal access approaches to oesophagectomy for cancer. Br J Surg 97:1845–1853PubMedCrossRef
2.
Zurück zum Zitat Willer BL, Mittal SK, Worrell SG et al (2010) Applicability and feasibility of incorporating minimally invasive esophagectomy at a high volume center. J Gastrointest Surg 14:1201–1206PubMedCrossRef Willer BL, Mittal SK, Worrell SG et al (2010) Applicability and feasibility of incorporating minimally invasive esophagectomy at a high volume center. J Gastrointest Surg 14:1201–1206PubMedCrossRef
3.
Zurück zum Zitat Nagpal K, Ahmed K, Vats A et al (2010) Is minimally invasive surgery beneficial in the management of esophageal cancer? A meta-analysis. Surg Endosc 24:1621–1629PubMedCrossRef Nagpal K, Ahmed K, Vats A et al (2010) Is minimally invasive surgery beneficial in the management of esophageal cancer? A meta-analysis. Surg Endosc 24:1621–1629PubMedCrossRef
4.
Zurück zum Zitat Verhage RJ, Hazebroek EJ, Boone J et al (2009) Minimally invasive surgery compared to open procedures in esophagectomy for cancer: a systematic review of the literature. Minerva Chir 64:135–146PubMed Verhage RJ, Hazebroek EJ, Boone J et al (2009) Minimally invasive surgery compared to open procedures in esophagectomy for cancer: a systematic review of the literature. Minerva Chir 64:135–146PubMed
5.
Zurück zum Zitat Bizekis C, Kent MS, Luketich JD et al (2006) Initial experience with minimally invasive Ivor Lewis esophagectomy. Ann Thorac Surg 82:402–406PubMedCrossRef Bizekis C, Kent MS, Luketich JD et al (2006) Initial experience with minimally invasive Ivor Lewis esophagectomy. Ann Thorac Surg 82:402–406PubMedCrossRef
6.
Zurück zum Zitat Santillan AA, Farma JM, Meredith KL et al (2008) Minimally invasive surgery for esophageal cancer. J Natl Compr Cancer Netw 6:879–884 Santillan AA, Farma JM, Meredith KL et al (2008) Minimally invasive surgery for esophageal cancer. J Natl Compr Cancer Netw 6:879–884
7.
Zurück zum Zitat Luketich JD, Alvelo-Rivera M, Buenaventura PO et al (2003) Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 238:486–494PubMed Luketich JD, Alvelo-Rivera M, Buenaventura PO et al (2003) Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 238:486–494PubMed
9.
Zurück zum Zitat Biere SS, van Berge Henegouwen MI, Maas KW et al (2012) Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 379:1887–1892PubMedCrossRef Biere SS, van Berge Henegouwen MI, Maas KW et al (2012) Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 379:1887–1892PubMedCrossRef
10.
Zurück zum Zitat Clark J, Sodergren MH, Purkayastha S et al (2011) The role of robotic assisted laparoscopy for oesophagogastric oncological resection; an appraisal of the literature. Dis Esophagus 24:240–250PubMedCrossRef Clark J, Sodergren MH, Purkayastha S et al (2011) The role of robotic assisted laparoscopy for oesophagogastric oncological resection; an appraisal of the literature. Dis Esophagus 24:240–250PubMedCrossRef
11.
Zurück zum Zitat Horgan S, Berger RA, Elli EF et al (2003) Robotic-assisted minimally invasive transhiatal esophagectomy. Am Surg 69:624–626PubMed Horgan S, Berger RA, Elli EF et al (2003) Robotic-assisted minimally invasive transhiatal esophagectomy. Am Surg 69:624–626PubMed
12.
Zurück zum Zitat Talamini MA, Chapman S, Horgan S et al (2003) A prospective analysis of 211 robotic-assisted surgical procedures. Surg Endosc 17:1521–1524PubMedCrossRef Talamini MA, Chapman S, Horgan S et al (2003) A prospective analysis of 211 robotic-assisted surgical procedures. Surg Endosc 17:1521–1524PubMedCrossRef
13.
Zurück zum Zitat Bodner J, Wykypiel H, Wetscher G et al (2004) First experiences with the da Vinci operating robot in thoracic surgery. Eur J Cardiothorac Surg 25:844–851PubMedCrossRef Bodner J, Wykypiel H, Wetscher G et al (2004) First experiences with the da Vinci operating robot in thoracic surgery. Eur J Cardiothorac Surg 25:844–851PubMedCrossRef
14.
Zurück zum Zitat Ruurda JP, Gooszen HG, Broeders IA (2004) Early experience in robot-assisted laparoscopic Heller myotomy. Scand J Gastroenterol Suppl (241): 4–8 Ruurda JP, Gooszen HG, Broeders IA (2004) Early experience in robot-assisted laparoscopic Heller myotomy. Scand J Gastroenterol Suppl (241): 4–8
15.
Zurück zum Zitat Gutt CN, Bintintan VV, Köninger J et al (2006) Robotic-assisted transhiatal esophagectomy. Langenbecks Arch Surg 391:428–434PubMedCrossRef Gutt CN, Bintintan VV, Köninger J et al (2006) Robotic-assisted transhiatal esophagectomy. Langenbecks Arch Surg 391:428–434PubMedCrossRef
16.
Zurück zum Zitat Giulianotti PC, Coratti A, Angelini M et al (2003) Robotics in general surgery: personal experience in a large community hospital. Arch Surg 138:777–784PubMedCrossRef Giulianotti PC, Coratti A, Angelini M et al (2003) Robotics in general surgery: personal experience in a large community hospital. Arch Surg 138:777–784PubMedCrossRef
17.
Zurück zum Zitat Anderson C, Hellan M, Kernstine K et al (2007) Robotic surgery for gastrointestinal malignancies. Int J Med Robot 3:297–300PubMedCrossRef Anderson C, Hellan M, Kernstine K et al (2007) Robotic surgery for gastrointestinal malignancies. Int J Med Robot 3:297–300PubMedCrossRef
18.
Zurück zum Zitat Galvani CA, Gorodner MV, Moser F et al (2008) Robotically assisted laparoscopic transhiatal esophagectomy. Surg Endosc 22:188–195PubMedCrossRef Galvani CA, Gorodner MV, Moser F et al (2008) Robotically assisted laparoscopic transhiatal esophagectomy. Surg Endosc 22:188–195PubMedCrossRef
19.
Zurück zum Zitat Kernstine KH, DeArmond DT, Shamoun DM et al (2007) The first series of completely robotic esophagectomies with three-field lymphadenectomy: initial experience. Surg Endosc 21:2285–2292PubMedCrossRef Kernstine KH, DeArmond DT, Shamoun DM et al (2007) The first series of completely robotic esophagectomies with three-field lymphadenectomy: initial experience. Surg Endosc 21:2285–2292PubMedCrossRef
21.
Zurück zum Zitat Espat NJ, Jacobsen G, Horgan S et al (2005) Minimally invasive treatment of esophageal cancer: laparoscopic staging to robotic esophagectomy. Cancer J 11:10–17PubMedCrossRef Espat NJ, Jacobsen G, Horgan S et al (2005) Minimally invasive treatment of esophageal cancer: laparoscopic staging to robotic esophagectomy. Cancer J 11:10–17PubMedCrossRef
22.
Zurück zum Zitat van Hillegersberg R, Boone J, Draaisma W et al (2006) First experience with robot-assisted thoracoscopic esophagolymphadenectomy for esophageal cancer. Surg Endosc 20:1435–1439PubMedCrossRef van Hillegersberg R, Boone J, Draaisma W et al (2006) First experience with robot-assisted thoracoscopic esophagolymphadenectomy for esophageal cancer. Surg Endosc 20:1435–1439PubMedCrossRef
23.
Zurück zum Zitat Boone J, Schipper ME, Moojen WA et al (2009) Robot-assisted thoracoscopic oesophagectomy for cancer. Br J Surg 96:878–886PubMedCrossRef Boone J, Schipper ME, Moojen WA et al (2009) Robot-assisted thoracoscopic oesophagectomy for cancer. Br J Surg 96:878–886PubMedCrossRef
24.
Zurück zum Zitat Kim DJ, Hyung WJ, Lee CY et al (2010) Thoracoscopic esophagectomy for esophageal cancer: feasibility and safety of robotic assistance in the prone position. J Thorac Cardiovasc Surg 139:53–59PubMedCrossRef Kim DJ, Hyung WJ, Lee CY et al (2010) Thoracoscopic esophagectomy for esophageal cancer: feasibility and safety of robotic assistance in the prone position. J Thorac Cardiovasc Surg 139:53–59PubMedCrossRef
25.
Zurück zum Zitat Puntambekar SP, Rayate N, Joshi S et al (2011) Robotic transthoracic esophagectomy in the prone position: experience with 32 patients with esophageal cancer. J Thorac Cardiovasc Surg 142:1283–1284PubMedCrossRef Puntambekar SP, Rayate N, Joshi S et al (2011) Robotic transthoracic esophagectomy in the prone position: experience with 32 patients with esophageal cancer. J Thorac Cardiovasc Surg 142:1283–1284PubMedCrossRef
27.
Zurück zum Zitat Landry CS, Grubbs EG, Stephen Morris G et al (2011) Robot assisted transaxillary surgery (RATS) for the removal of thyroid and parathyroid glands. Surgery 149:549–555PubMedCrossRef Landry CS, Grubbs EG, Stephen Morris G et al (2011) Robot assisted transaxillary surgery (RATS) for the removal of thyroid and parathyroid glands. Surgery 149:549–555PubMedCrossRef
28.
Zurück zum Zitat Lee J, Yun JH, Nam KH et al (2011) Perioperative clinical outcomes after robotic thyroidectomy for thyroid carcinoma: a multicenter study. Surg Endosc 25:906–912PubMedCrossRef Lee J, Yun JH, Nam KH et al (2011) Perioperative clinical outcomes after robotic thyroidectomy for thyroid carcinoma: a multicenter study. Surg Endosc 25:906–912PubMedCrossRef
29.
Zurück zum Zitat Bokhari MB, Patel CB, Ramos-Valadez DI et al (2011) Learning curve for robotic-assisted laparoscopic colorectal surgery. Surg Endosc 25:855–860PubMedCrossRef Bokhari MB, Patel CB, Ramos-Valadez DI et al (2011) Learning curve for robotic-assisted laparoscopic colorectal surgery. Surg Endosc 25:855–860PubMedCrossRef
30.
Zurück zum Zitat Hayn MH, Hussain A, Mansour AM et al (2010) The learning curve of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol 58:197–202PubMedCrossRef Hayn MH, Hussain A, Mansour AM et al (2010) The learning curve of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol 58:197–202PubMedCrossRef
31.
Zurück zum Zitat Meredith KL, Weber JM, Turaga KK et al (2010) Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer. Ann Surg Oncol 17:1159–1167PubMedCrossRef Meredith KL, Weber JM, Turaga KK et al (2010) Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer. Ann Surg Oncol 17:1159–1167PubMedCrossRef
32.
Zurück zum Zitat Melis M, Weber JM, McLoughlin JM et al (2011) An elevated body mass index does not reduce survival after esophagectomy for cancer. Ann Surg Oncol 18:824–831PubMedCrossRef Melis M, Weber JM, McLoughlin JM et al (2011) An elevated body mass index does not reduce survival after esophagectomy for cancer. Ann Surg Oncol 18:824–831PubMedCrossRef
Metadaten
Titel
Initial experience from a large referral center with robotic-assisted Ivor Lewis esophagogastrectomy for oncologic purposes
verfasst von
Sebastian G. de la Fuente
Jill Weber
Sarah E. Hoffe
Ravi Shridhar
Richard Karl
Kenneth L. Meredith
Publikationsdatum
01.09.2013
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 9/2013
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-013-2915-6

Weitere Artikel der Ausgabe 9/2013

Surgical Endoscopy 9/2013 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.